Serum Institute gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine
82,961 COVID-19 patients were cured and discharged in the last 24 hours
Full Article
Serum Institute gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine
Hindu
0 shares
1 views
You might like
Related news coverage
Oxford Covid vaccine: AstraZeneca still waiting for FDA nod to resume US trial
WorldNews
AstraZeneca is still waiting for the U.S. drug regulator to approve the restart of the clinical trial of its potential COVID-19..
-
Mumbai: Clinical trial of COVID-19 vaccine begins at KEM, Nair hospitals
Mid-Day
-
Can Centre procure Rs 80,000 crore to buy, distribute COVID-19 vaccine across India? SII CEO Adar Poonawalla
DNA
-
Can Centre procure Rs 80,000 crore to buy, distribute COVID-19 vaccine across India? SII CEO Adar Poonawalla asks
DNA
-
Mumbai: KEM hospital gets gets nod for COVID-19 vaccine trials
Mid-Day
Advertisement
More coverage
Phase 3 human clinical trial of Oxford vaccine begins in Pune
IndiaTimes
The phase-III human clinical trial of the Covid-19 vaccine being developed by Oxford University, and manufactured by the Serum..